BiohaQ NAD+ CELL ENERGY – terapie IV cu NAD+

BiohaQ NAD+ Cell Energy 600

2.500,00 lei
Skip to product information
BiohaQ NAD+ CELL ENERGY – terapie IV cu NAD+

BiohaQ NAD+ Cell Energy 600

2.500,00 lei

NAD+ and cellular energy metabolism

As we age, the body's natural NAD+ levels tend to decline. NAD+ is an essential coenzyme involved in cellular energy production and in numerous metabolic processes that contribute to the normal functioning of the body.

NAD+ IV therapy aims to support energy metabolism and mitochondrial function. Intravenous administration allows the coenzyme to be delivered directly, with the protocol personalised according to the medical assessment and each patient's goals.

See more →

What is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of the body, involved in energy production (ATP), mitochondrial function and numerous metabolic processes. Its levels may decline with age and during periods of stress or intense exertion.

When can it be considered?

  • When the medical assessment identifies a need to support energy metabolism.
  • During periods of tiredness and physical or mental overload, after other causes have been ruled out.
  • In athletes, during recovery periods after intense exertion.
  • As part of a personalised health and longevity plan established by the doctor.

How do we use the therapy?

Before starting the therapy, a full medical assessment is carried out and, where indicated, a set of relevant tests. The protocol is established individually, according to the patient's medical history and goals.

  • Personalised dosage: 600 mg
  • Administration: slow intravenous infusion using an infusion pump, under medical supervision.
  • Assessment: contraindications and eligibility are determined during the medical consultation.

Important medical information

NAD+ is administered only after a medical assessment. During the infusion, a feeling of chest pressure, nausea, abdominal cramps or discomfort may occur, which is why the infusion rate is slow and adapted to tolerance. The benefits of routine intravenous administration for increasing energy, performance or longevity are not supported by sufficient clinical evidence.


A personalised protocol, established after a medical assessment.

You may also like...